Pitch for Investment

Latest Insights, Interviews, News, and Resources.

The latest news from UKI2S and our portfolio companies

Oxford AI Startup Astut Raises £1.6m to Solve “Never-Before-Seen” Business Crises Without Historical Data

23rd October 2025

Astut, the Oxfordshire-based Hybrid AI company, announces growth investment co-led by technology VCs East X Ventures and SVV (Sure Valley Ventures).
Early Detection for All: Sona's New ground-breaking Ultrasound Tech

Early Detection for All: Sona’s New ground-breaking Ultrasound Tech to Make Breast Cancer Screening More Efficient and Save Lives

20th November 2024

Sona, from the world-leading National Physical Laboratory (NPL), will revolutionise breast cancer screening with world’s first innovative ultrasound-based breast density assessment and monitoring technology, that does not require imaging or trained radiologists.
Patient having temperature taken.

MoD spin-out Presymptom Health raises £1.5m to develop AI-driven sepsis and infection tests for the NHS

22nd March 2024

UK start-up Presymptom Health has raised £1.5m in follow-on seed and grant funding that will help accelerate time to market of its AI-driven sepsis and infection tests.
image of presympton health

UKI2S portfolio company, Presymptom Health, joins government pilot

15th February 2024

To get AI-driven infection test into the NHS faster helping to tackle Anti-Microbial Resistance.
Iain Miller, CEO of PreSymptom Health

CEO Spotlight: Iain Miller, CEO of PreSymptom Health

6th December 2022

You develop an instinct through your career. Like an experienced driver, you start to see problems before they happen, you come to know that the car at the junction ahead might come out…
Neil Martin

CEO Spotlight: Neil Martin, CEO Vector Photonics

6th September 2021

Vector Photonics is a spin-out from the University of Glasgow, based on world-leading semiconductor research led by Professor Richard Hogg.
national cancer institute

Presymptom Health Receives Additional Funding to Support its Trials of an Early Test for Sepsis

25th August 2021

Medical technology company Presymptom Health has successfully closed its seed round funding to support the development of its pioneering blood test for the early detection of sepsis.
UKI2S

© UKI2S and Future Planet Capital (Ventures) Limited. All Rights Reserved. UKI2S is managed by Future Planet Capital (Ventures) Limited which is Authorised and Regulated in the UK by the Financial Conduct Authority FRN 148549. Registered in England and Wales. Company Number 2500898. Registered Address: Future Planet Capital (Ventures) Limited, 1 Scott Place, 2 Hardman Street, Manchester, M3 3AA.

Stay updated

UKI2S
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.